Foster City, CA, United States
Foster City, CA, United States

Time filter

Source Type

Marini N.J.,University of California at Berkeley | Hoffmann T.J.,University of California at San Francisco | Lammer E.J.,Childrens Hospital Oakland Research Institute | Hardin J.,VitaPath Genetics | And 10 more authors.
PLoS ONE | Year: 2011

Despite compelling epidemiological evidence that folic acid supplements reduce the frequency of neural tube defects (NTDs) in newborns, common variant association studies with folate metabolism genes have failed to explain the majority of NTD risk. The contribution of rare alleles as well as genetic interactions within the folate pathway have not been extensively studied in the context of NTDs. Thus, we sequenced the exons in 31 folate-related genes in a 480-member NTD case-control population to identify the full spectrum of allelic variation and determine whether rare alleles or obvious genetic interactions within this pathway affect NTD risk. We constructed a pathway model, predetermined independent of the data, which grouped genes into coherent sets reflecting the distinct metabolic compartments in the folate/one-carbon pathway (purine synthesis, pyrimidine synthesis, and homocysteine recycling to methionine). By integrating multiple variants based on these groupings, we uncovered two provocative, complex genetic risk signatures. Interestingly, these signatures differed by race/ethnicity: a Hispanic risk profile pointed to alterations in purine biosynthesis, whereas that in non-Hispanic whites implicated homocysteine metabolism. In contrast, parallel analyses that focused on individual alleles, or individual genes, as the units by which to assign risk revealed no compelling associations. These results suggest that the ability to layer pathway relationships onto clinical variant data can be uniquely informative for identifying genetic risk as well as for generating mechanistic hypotheses. Furthermore, the identification of ethnic-specific risk signatures for spina bifida resonated with epidemiological data suggesting that the underlying pathogenesis may differ between Hispanic and non-Hispanic groups.


Patent
VitaPath Genetics and The Regents Of The University Of California | Date: 2010-09-30

Provided herein are methods and systems for identifying one or more cofactors such as vitamins for individuals based on the genetic makeup of the individual by detecting the presence or absence of at least one genetic variant, determining a predisposition to cofactor remediable condition, generating a personalized nutritional advice plan based on the genetic variant. Also provided herein are formulations of cofactors determined by the genetic make-up of the individual and methods of determining and producing these formulations.


Trademark
VitaPath Genetics | Date: 2012-08-07

Medical test kits used to perform DNA tests which indicate predisposition for medical disease for professional use, comprised of devices used to collect DNA.


Trademark
VitaPath Genetics | Date: 2010-12-14

Computer software and downloadable computer software for mobile devices used to track folate consumption.


OK [PR]


2 This entry was posted in . Bookmark the permalink


Loading VitaPath Genetics collaborators
Loading VitaPath Genetics collaborators